Pyxis Oncology



Pyxis Oncology is advancing a differentiated portfolio of potent biologics, including antibody-drug conjugates (ADCs) and monoclonal antibody (mAb) immunotherapies with the potential to help patients suffering from difficult-to-treat cancers.


Add photos to showcase Pyxis Oncology’s culture


Add Pyxis Oncology’s values

Insider experiences

Share your experience of working at Pyxis Oncology

Lara S. Sullivan
Chief Executive Officer
Robert Crane
Chief Financial Officer
Ronald Herbst
Chief Scientific Officer
Steve Monks
Chief Technical Officer
Ritu Shah
Chief Operating Officer
James Mutamba
VP of Business & Corporate Development

Add your teams to show how people work together at Pyxis Oncology

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.